Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

Publisher Name :
Date: 12-Jun-2018
No. of pages: 188
Inquire Before Buying

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape.

Retinitis Pigmentosa (RP) refers to a group of diseases which cause a slow but progressive vision loss. Retinitis pigmentosa is caused by a genetic defect. Symptoms include night blindness and loss of peripheral vision. The predisposing factors include autosomal dominant inheritance, autosomal recessive inheritance and x-linked inheritance.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Retinitis Pigmentosa (Retinitis) (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Retinitis Pigmentosa (Retinitis) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 2, 12, 3, 31 and 7 respectively. Similarly, the Universities portfolio in Phase I and Preclinical stages comprises 1 and 11 molecules, respectively.

Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Retinitis Pigmentosa (Retinitis) (Ophthalmology).

- The pipeline guide reviews pipeline therapeutics for Retinitis Pigmentosa (Retinitis) (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Retinitis Pigmentosa (Retinitis) (Ophthalmology) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Retinitis Pigmentosa (Retinitis) (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Retinitis Pigmentosa (Retinitis) (Ophthalmology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Retinitis Pigmentosa (Retinitis) (Ophthalmology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

Table of Contents
Table of Contents 2
Introduction 5
Retinitis Pigmentosa (Retinitis) - Overview 6
Retinitis Pigmentosa (Retinitis) - Therapeutics Development 7
Retinitis Pigmentosa (Retinitis) - Therapeutics Assessment 18
Retinitis Pigmentosa (Retinitis) - Companies Involved in Therapeutics Development 26
Retinitis Pigmentosa (Retinitis) - Drug Profiles 40
Retinitis Pigmentosa (Retinitis) - Dormant Projects 162
Retinitis Pigmentosa (Retinitis) - Discontinued Products 164
Retinitis Pigmentosa (Retinitis) - Product Development Milestones 165
Appendix 180

List of Tables
Number of Products under Development for Retinitis Pigmentosa (Retinitis), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Products under Development by Companies, H1 2018 (Contd..3), H1 2018
Products under Development by Universities/Institutes, H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Acucela Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Allergan Plc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Amarantus Bioscience Holdings Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Amgen Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Applied Genetic Technologies Corp, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Astellas Pharma Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Dompe Farmaceutici SpA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by EyePoint Pharmaceuticals Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Eyevensys SAS, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by GenSight Biologics SA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Grupo Ferrer Internacional SA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Horama SA, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by ID Pharma Co Ltd, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by InFlectis BioScience, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Ionis Pharmaceuticals Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by M's Science Corp, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by MimeTech Srl, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Miragen Therapeutics Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Nanovector srl, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Novartis AG, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Novelion Therapeutics Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Profarma, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by ProQR Therapeutics NV, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Recursion Pharmaceuticals Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by ReNeuron Group Plc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by SanBio Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Sanofi, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Spark Therapeutics Inc, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Sumitomo Dainippon Pharma Co Ltd, H1 2018
Retinitis Pigmentosa (Retinitis) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2018
Retinitis Pigmentosa (Retinitis) - Dormant Projects, H1 2018
Retinitis Pigmentosa (Retinitis) - Dormant Projects, H1 2018 (Contd..1), H1 2018
Retinitis Pigmentosa (Retinitis) - Discontinued Products, H1 2018

List of Figures
Number of Products under Development for Retinitis Pigmentosa (Retinitis), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Universities/Institutes, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Top 10 Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Molecule Types, H1 2018
  • Global Darbepoetin Alfa Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 97
    This report studies the global market size of Darbepoetin Alfa in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Darbepoetin Alfa in these regions. This research report categorizes the global Darbepoetin Alfa market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportuni......
  • Global CAD CAM Dental Milling Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 15-Aug-2018        Price: US 3480 Onwards        Pages: 145
    This report mainly focused on dental CAD/CAM Milling Machine systems. CAD/CAM Milling Machine uses CAD/CAM (computer-aided design and computer-aided manufacturing), using rotary burs, to produce dental prostheses, including crowns, crown lays, veneers, inlays and onlays, fixed bridges, dental implant restorations, dentures (removable or fixed), etc. Scope of the Report: This report focuses on the CAD CAM Dental Milling in global market, especially in North America, Europe a......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) CAD CAM Dental Milling Market 2018, Forecast to 2023
    Published: 15-Aug-2018        Price: US 4880 Onwards        Pages: 152
    This report mainly focused on dental CAD/CAM Milling Machine systems. CAD/CAM Milling Machine uses CAD/CAM (computer-aided design and computer-aided manufacturing), using rotary burs, to produce dental prostheses, including crowns, crown lays, veneers, inlays and onlays, fixed bridges, dental implant restorations, dentures (removable or fixed), etc. Scope of the Report: This report focuses on the CAD CAM Dental Milling in global market, especially in North America, Europe a......
  • Global Follicle Stimulating Hormone Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 135
    Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. Scope of the Report: This report focuses on the Follicle Stimulating Hormone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Follicle Stimulating Hormone Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 131
    Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. Scope of the Report: This report focuses on the Follicle Stimulating Hormone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. ......
  • Global Human Growth Hormone Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 128
    Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituit......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Human Growth Hormone Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 137
    Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituit......
  • Global Amebocyte Lysate Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 135
    Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins. Scope of the Report: This report focuses on the Amebocyte Lysate in global market, especially......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Amebocyte Lysate Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 128
    Amebocyte Lysate is an aqueous extract of blood cells from the Atlantic horseshoe crab or oriental horseshoe crab. Amebocyte Lysate reacts with bacterial endotoxin lipopolysaccharide (LPS), which is a membrane component of gram negative bacteria. This reaction is the basis of the Amebocyte Lysate test, which is then used for the detection and quantification of bacterial endotoxins. Scope of the Report: This report focuses on the Amebocyte Lysate in global market, especially......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs